elinzanetant
Small moleculeapproved
Approved
Oct 24, 2025
Clinical trial activity
17 trials · 2 clinical orgs · 1 marketing orgs
Phase 1
11
Phase 2
6
Phase 3
4
Phase 4
0
Earliest trial started Apr 9, 2021 (NCT04845841)
Timeline
Indications
Approved for
Mechanism of action
- Neurokinin 3 receptorANTAGONIST
TACR3 antagonist
- Neurokinin 1 receptorANTAGONIST
TACR1 antagonist
Approval history
- approvedOct 24, 2025
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(F)ccc1-c1cc(N2C[C@H]3COCCN3C[C@H]2CO)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1- Mol. weight
- 668.65 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4802157 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07077395 | Phase 2 | Jan 31, 2026 | Harvard University |
| NCT06219902 | Phase 1 | Jan 8, 2024 | Bayer |
| NCT06112756 | Phase 2 | Nov 8, 2023 | Bayer |
| NCT05587296 | Phase 3 | Oct 14, 2022 | Bayer |
| NCT05481528 | Phase 1 | Aug 19, 2022 | Bayer |
| NCT05471817 | Phase 1 | Aug 5, 2022 | Bayer |
| NCT05381142 | Phase 1 | May 23, 2022 | Bayer |
| NCT05351892 | Phase 1 | May 4, 2022 | Bayer |
| NCT05099159 | Phase 3 | Oct 29, 2021 | Bayer |
| NCT05071729 | Phase 1 | Oct 14, 2021 | Bayer |
| NCT05061563 | Phase 1 | Sep 30, 2021 | Bayer |
| NCT05028608 | Phase 1 | Sep 6, 2021 | Bayer |
| NCT05042362 | Phase 3 | Aug 27, 2021 | Bayer |
| NCT05030584 | Phase 3 | Aug 27, 2021 | Bayer |
| NCT04981431 | Phase 1 | Aug 11, 2021 | Bayer |
| NCT04889287 | Phase 1 | May 26, 2021 | Bayer |
| NCT04845841 | Phase 1 | Apr 9, 2021 | Bayer |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 16 | 16 | 3 | 2021 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2026 |
2 organizations
Page 1 / 1
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Bayer | For profit | MKTG | Oct 24, 2025 |